home new2022-10-13T14:54:37-07:00

Featured Articles

Merck to invest $1B in new US plant to make blockbuster cancer…

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said. Merck said last week its biggest...

Featured STOCK

 
Go to Top